1520ai and Hospice Analytics Announce Strategic Combination to Advance Data-Driven Hospice Care and AI Innovation
You are unauthorized to view this page. Username Password Remember Me Forgot Password
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Bourne Partners is hearing more and more from its biopharma, contract research organization (CRO), and trial site network relationships about potential opportunities to use artificial intelligence (AI) to better design and execute clinical trials –particularly as drug development becomes increasingly complex. In parallel, Bourne Partners sees vertical SaaS vendors in the clinical trial space successfully
Bourne Partners Clinical Trial Technologies Marketplace Update Read More »
You are unauthorized to view this page.
Bourne Partners Clinical Trial Technologies Marketplace Update Read More »
The Food and Drug Administration has kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs. The agency announced the launch of two “proof of concept” real-time trials to view safety and efficacy signals for an AstraZeneca drug
FDA to Use AI to Track Clinical Trials in Real Time Read More »
You are unauthorized to view this page.
FDA to Use AI to Track Clinical Trials in Real Time Read More »
Aesthetic Record, the EMR and practice management platform trusted by more than 30,000 aesthetic providers nationwide, announces its acquisition of JOYA Health, a corporate skin health and wellness benefit that connects employers/employees to credentialed dermatological and aesthetic care. As voluntary benefits become a core employer strategy, JOYA has emerged as a standout: ~40% member utilization
Corporate Technologies, a national managed IT services and cybersecurity provider for small and mid-sized businesses, announces the acquisition of RPM Technologies, LLC, a managed services provider known for its deep expertise in Life Sciences and other highly regulated industries. The acquisition expands Corporate Technologies’ presence to 21 markets nationwide and strengthens its ability to support
You are unauthorized to view this page.
Azra AI, the leading end-to-end enterprise platform for incidental findings and oncology workflow automation, announces the acquisition of Thynk Health, the specialized leader of lung cancer screening and incidental findings management. The deal unites two of healthcare’s most trusted names in imaging-driven care coordination, with a shared goal: ensuring that no patient falls through the
Azra AI Acquires Thynk Health to Close the Gap Between Imaging and Cancer Care Read More »